Navigation Links
Bradmer provides Phase III Neuradiab trial update and guidance
Date:10/15/2007

TSX: BMR

TORONTO, Oct. 15 /PRNewswire-FirstCall/ - Bradmer Pharmaceuticals Inc., a biopharmaceutical company dedicated to the development and commercialization of cancer therapies, today announced that it held a pre-Phase III meeting with the U.S. Food and Drug Administration (FDA) at which the FDA concurred with Bradmer's proposed design of the Phase III trial for its lead drug, Neuradiab, a treatment for newly diagnosed glioblastoma multiforme (GBM), the most common form of brain cancer.

At the recent meeting, the FDA responded favorably to the Company's presentation of its full clinical plan which included the trial protocol, standard operating procedures, statistical plan, and related documents.

"We initiated this discussion with the FDA to establish clarity around the appropriate clinical structure of a multicenter trial that would be suitable for the potential registration of Neuradiab," commented Alan M. Ezrin, Ph.D., President and Chief Executive Officer of Bradmer. "We are delighted with the FDA's response to the presentation of our clinical plans, which were developed in conjunction with the FDA, with our collaborators at Duke University and with thought leaders in neurooncology and neurosurgery."

Bradmer and the FDA discussed and agreed to the study trial design which includes an enhanced statistical power calculation of 90% and an added interim efficacy analysis. The agreed design, which will allow for the enrollment of approximately 380 patients in each of the experimental and control arms, has the possibility to actually shorten the study trial duration and to improve the statistical probability of success. Bradmer anticipates a 24-month enrollment period and an interim efficacy analysis on overall survival at approximately month 39 post-trial initiation, or at 470 mortality events. Should an additional efficacy analysis be required, it would occur at 626 events.

Prior to the initiatio
'/>"/>

SOURCE Bradmer Pharmaceuticals Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Protein provides antioxidant protection to Neurons
2. Acupuncture provides relief
3. Micro-camera provides new breast imaging technique
4. Hormone therapy provides no heart benefit
5. MicroRNA provides new insight into birth defects
6. Drug Spironolactone Provides Renal And Cardioprotection In Diabetic Patients
7. Neurobiology Provides Answers To Block Memory-Related Drug Cravings
8. Cholesterol provides immunity against infection by certain parasites
9. John Hopkins CGHH program provides Global Health education
10. London Hospital Provides Specialized Care For Pregnant Women
11. Hope Lodges provides free stay to cancer patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... The Down Syndrome Association of Wisconsin (DSAW) is ... Glee as the keynote speaker for its June 6, ... The event aims to raise funds to support programs ... counties. , "We couldn't be more ... event," says Dawn Nuoffer, DSAW Executive Director. "She's a ...
(Date:6/2/2015)... New Jersey (PRWEB) June 02, 2015 ... (Horizon BCBSNJ) announced today that its Walking and Wellness ... Classic Presented by Acer, has raised another $3,000 for ... Natalie Gulbis undertook the challenge, recording 32,000 steps on ... at Stockton Seaview Hotel & Golf Club in Galloway ...
(Date:6/2/2015)... (PRWEB) June 02, 2015 “ Radaris ” ... which takes a look at the latest and coolest applications ... the host of AppWatch and technology expert, conducted the app ... the data they need on a person. , According to ... publication even goes on to explain that curiosity is a ...
(Date:6/2/2015)... October 1, 2015 the transition to ICD-10 will happen ... Monday, June 1st Congressman Kevin Brady, chairman of ... Committee, and 12 members of the Committee sent a ... the administration to provide a smooth transition for local ... newest coding system for healthcare professionals to code diseases, ...
(Date:6/2/2015)... (PRWEB) June 02, 2015 Claflin ... distributor, has announced the acquisition of RSI ... distributor, effective May 29th, 2015. , With CME’s recent ... this latest acquisition joins three premier organizations which specialize ... hospitals and healthcare facilities. By combining forces, they now ...
Breaking Medicine News(10 mins):Health News:Glee star Lauren Potter helps Down Syndrome Association of WI raise awareness, support 2Health News:LPGA’s Natalie Gulbis Raises an Additional $3,000 for the Boys & Girls Club of Atlantic City Through Horizon BCBSNJ’s Walking and Wellness Challenge 2Health News:A Comprehensive People Search Application Was Featured on NewsWatch Television 2Health News:HomeTown Health Launches a “100 Day Countdown” in Response to ICD-10 Survey 2Health News:HomeTown Health Launches a “100 Day Countdown” in Response to ICD-10 Survey 3Health News:HomeTown Health Launches a “100 Day Countdown” in Response to ICD-10 Survey 4Health News:Claflin Medical Equipment (CME) Announces Acquisition of RSI Equipment, Inc. 2
... , AUGUSTA, Ga. Scientists want to protect the optic nerve ... a car wreck. It,s called traumatic optic nerve damage when ... gets rattled, resulting in swelling and inflammation that can destroy its ... loss and blindness. "The optic nerve is not completely straight ...
... has named Takeo Kanade, the U.A. and Helen Whitaker ... Mellon University, the 2010 winner of the ACM/AAAI Allen ... and robotics. , The Newell Award, named for one ... Computer Science, recognizes career contributions that have breadth within ...
... lead-based ammunition as a potential health and environmental hazard, ... material for bullets tungsten may not be ... accumulates in major structures of the immune system in ... Toxicology . Jose Centeno and colleagues explain that ...
... 2011) Breast cancer is the second most common cancer ... Being exposed to estrogen over a long period of time ... developing the disease. One way a woman can combat ... tamoxifen, which interferes with the activity of estrogen. Now, ...
... not really be compatible with current beauty ideals, but, to a ... our body. However, it is a different matter if the organism ... This is a clear sign of a metabolic disorder. ... which is regarded a typical characteristic of the dangerous metabolic syndrome. ...
... , TUESDAY, April 5 (HealthDay News) -- In the ... researchers report that risks to postmenopausal women who were ... the treatment. The study found that when ... blood clots, which were elevated while they were on ...
Cached Medicine News:Health News:Better treatment sought for blinding traumatic optic nerve damage 2Health News:CMU's Takeo Kanade wins ACM/AAAI Award for career contributions to computer vision, robotics 2Health News:Fox Chase researchers find that fish oil boosts responses to breast cancer drug tamoxifen 2Health News:Fatty liver -- how a serious problem arises 2Health News:Risks of Estrogen Hormone Therapy Seen to Fade After Treatment Ends 2Health News:Risks of Estrogen Hormone Therapy Seen to Fade After Treatment Ends 3
(Date:6/2/2015)... Research and Markets ( http://www.researchandmarkets.com/research/w3n5p6/drug_delivery_in ) ... report "Drug Delivery in Central Nervous System ... their offering. The delivery of drugs ... in the treatment of neurological disorders. Drugs may ... systematically (e.g., by intravenous injection) for targeted action ...
(Date:6/2/2015)... June 2, 2015 The Canadian Society for Vascular ... tests, treatments or procedures that are commonly ordered ... part of Choosing Wisely Canada.  The list identifies ... conversations between patients and physicians about what care ... for Vascular Surgery,s list identified the following five ...
(Date:6/2/2015)... , June 02, 2015 Research and Markets ( ... Archiving and Communication Systems (PACS) - Global Strategic Business Report" ... separate comprehensive analytics for the US, Canada ... , Asia-Pacific , Latin America ... and forecasts are provided for the period 2014 through 2020. ...
Breaking Medicine Technology:Global Drug Delivery in Central Nervous System Diseases Report 2015-2024 - Technologies, Markets and Companies 2Global Drug Delivery in Central Nervous System Diseases Report 2015-2024 - Technologies, Markets and Companies 3As part of the Choosing Wisely Canada campaign the Canadian Society for Vascular Surgery releases list of commonly used tests and treatments to question 2As part of the Choosing Wisely Canada campaign the Canadian Society for Vascular Surgery releases list of commonly used tests and treatments to question 3As part of the Choosing Wisely Canada campaign the Canadian Society for Vascular Surgery releases list of commonly used tests and treatments to question 4Picture Archiving and Communication Systems (PACS) - Global Strategic Business Report 2015: User Demand Favors Integrated RIS/PACS Solutions 2
... Bend Research Inc. ( www.bendresearch.com ), a leading independent ... McLeod has joined the company as Chief Financial Officer. ... McLeod was formerly Director of Business Development with ... strategic vision is credited with improving many different parts ...
... 2011 Comprehensive Care Corporation (OTC BB: CHCR), which ... services for managed care companies throughout the U.S., today ... been praised by the Chamber of Commerce of the ... Advisory Council in "helping to shape and drive the ...
Cached Medicine Technology:Bend Research Announces New Chief Financial Officer 2Comprehensive Care Corporation CEO Clark A. Marcus Praised for U.S. Chamber of Commerce Service 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: